Clinical trial
UARK 2003-41: A Phase II Study of High-Dose Density Therapy With Tandem Autologous Transplants for Patients With Multiple Myeloma
NCT00113932 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- UARK 2003-41: A Phase II Study of High-Dose Density Therapy With Tandem Autologous Transplants for Patients With Multiple Myeloma
- Lead sponsor
- University of Arkansas
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- July 31, 2010
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.